# Efficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple Sclerosis

> **NCT01720849** · — · UNKNOWN · sponsor: **Vestre Viken Hospital Trust** · enrollment: 50 (estimated)

## Conditions studied

- Multiple Sclerosis
- EDSS 4-7

## Interventions

- **DRUG:** Fampyra

## Key facts

- **NCT ID:** NCT01720849
- **Lead sponsor:** Vestre Viken Hospital Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2016-05
- **Final completion:** —
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2015-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720849, "Efficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01720849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*